Enrollment of older adults on oncology trials: An FDA perspective

J Geriatr Oncol. 2017 May;8(3):149-150. doi: 10.1016/j.jgo.2016.11.001. Epub 2016 Dec 23.

Authors

Harpreet Singh¹, Julia A Beaver², Geoffrey Kim², Richard Pazdur²

Affiliations

¹ Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, United States. Electronic address: Harpreet.Singh@fda.hhs.gov.
² Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, United States.

PMID: 28017686
DOI: 10.1016/j.jgo.2016.11.001

No abstract available

MeSH terms

Aged
Aged, 80 and over
Drug Development / trends*
Humans
Medical Oncology*
Patient Selection*
Randomized Controlled Trials as Topic*
United States
United States Food and Drug Administration